Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Biovectra Inc.
Biovectra Inc.
Activities:
Ingredients
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
BioVectra unveils single-use microbial fermentation technology
Benefits include a decreased risk of contamination, and the elimination of costly and time-consuming cleaning and sterilisation between batches
Manufacturing
Abec to supply fermentation tech for Biovectra plant
The single-use fermentation solutions will enhance the company’s microbial fermentation processes and provide faster turnaround product to product and between batches
Manufacturing
Mallinckrodt sells BioVectra CDMO for $250 million
The Canadian CDMO will continue to supply an API for UK-based Mallinckrodt's specialty brands business under a long-term arrangement
Manufacturing
Questcor Pharmaceuticals to acquire BioVectra
Deal enables Questcor to secure further Acthar manufacturing process trade secrets
Subscribe now